11 – 20 of 624
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden : LYMPHOMA
- Contribution to journal › Letter
-
Mark
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor : The AGITG ALT-GIST intergroup randomized phase II trial: Clinical Studies
- Contribution to journal › Article
-
Mark
Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies
- Contribution to journal › Letter
-
Mark
Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies
- Contribution to journal › Article
-
Mark
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer : insights from the randomized SweBCG91RT trial
- Contribution to journal › Article
-
Mark
Inter-reader agreement of quantitative FDG PET/CT biomarkers in lymphoma : a multicentre evaluation of MTV, TLG and Dmax
- Contribution to journal › Article
-
Mark
Empati och kommunikation i fokus, en ny modell i läkarutbildningen
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Quality of life as a predictor for survival in patients with small intestinal neuroendocrine tumours
- Contribution to journal › Article
-
Mark
Increasing credibility in government assignments : an example from Sweden of stakeholder involvement by using Concept Mapping
- Contribution to journal › Article
-
Mark
Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma
(2025) In International Journal of Cancer
- Contribution to journal › Article
